Intranasal Esketamine Effective for Geriatric Patients With Treatment-Resistant Depression
Intranasal esketamine in combination with oral antidepressants demonstrated significant reduction of depressive symptoms and improved overall severity of depressive illness and health-related quality of life and functioning.